Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229006237> ?p ?o ?g. }
- W4229006237 endingPage "e069164" @default.
- W4229006237 startingPage "e069164" @default.
- W4229006237 abstract "Abstract Objectives To compare treatment and outcomes for patients admitted to hospital with a primary diagnosis of ST elevation or non-ST elevation myocardial infarction (STEMI or NSTEMI) in six high income countries with very different healthcare delivery systems. Design Retrospective cross sectional cohort study. Setting Patient level administrative data from the United States, Canada (Ontario and Manitoba), England, the Netherlands, Israel, and Taiwan. Participants Adults aged 66 years and older admitted to hospital with STEMI or NSTEMI between 1 January 2011 and 31 December 2017. Outcomes measures The three categories of outcomes were coronary revascularisation (percutaneous coronary intervention or coronary artery bypass graft surgery), mortality, and efficiency (hospital length of stay and 30 day readmission). Rates were standardised to the age and sex distribution of the US acute myocardial infarction population in 2017. Outcomes were assessed separately for STEMI and NSTEMI. Performance was evaluated longitudinally (over time) and cross sectionally (between countries). Results The total number of hospital admissions ranged from 19 043 in Israel to 1 064 099 in the US. Large differences were found between countries for all outcomes. For example, the proportion of patients admitted to hospital with STEMI who received percutaneous coronary intervention in hospital during 2017 ranged from 36.9% (England) to 78.6% (Canada; 71.8% in the US); use of percutaneous coronary intervention for STEMI increased in all countries between 2011 and 2017, with particularly large rises in Israel (48.4-65.9%) and Taiwan (49.4-70.2%). The proportion of patients with NSTEMI who underwent coronary artery bypass graft surgery within 90 days of admission during 2017 was lowest in the Netherlands (3.5%) and highest in the US (11.7%). Death within one year of admission for STEMI in 2017 ranged from 18.9% (Netherlands) to 27.8% (US) and 32.3% (Taiwan). Mean hospital length of stay in 2017 for STEMI was lowest in the Netherlands and the US (5.0 and 5.1 days) and highest in Taiwan (8.5 days); 30 day readmission for STEMI was lowest in Taiwan (11.7%) and the US (12.2%) and highest in England (23.1%). Conclusions In an analysis of myocardial infarction in six high income countries, all countries had areas of high performance, but no country excelled in all three domains. Our findings suggest that countries could learn from each other by using international comparisons of patient level nationally representative data." @default.
- W4229006237 created "2022-05-08" @default.
- W4229006237 creator A5001379502 @default.
- W4229006237 creator A5002235223 @default.
- W4229006237 creator A5010334043 @default.
- W4229006237 creator A5011877915 @default.
- W4229006237 creator A5014282030 @default.
- W4229006237 creator A5026598797 @default.
- W4229006237 creator A5034810517 @default.
- W4229006237 creator A5036366417 @default.
- W4229006237 creator A5057294957 @default.
- W4229006237 creator A5057483756 @default.
- W4229006237 creator A5066029617 @default.
- W4229006237 creator A5067051752 @default.
- W4229006237 creator A5068277747 @default.
- W4229006237 creator A5071026390 @default.
- W4229006237 creator A5072175850 @default.
- W4229006237 creator A5072276755 @default.
- W4229006237 creator A5082999537 @default.
- W4229006237 date "2022-05-04" @default.
- W4229006237 modified "2023-10-16" @default.
- W4229006237 title "Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study" @default.
- W4229006237 cites W12242896 @default.
- W4229006237 cites W1507178767 @default.
- W4229006237 cites W1950757583 @default.
- W4229006237 cites W1977776328 @default.
- W4229006237 cites W1993227299 @default.
- W4229006237 cites W1993564152 @default.
- W4229006237 cites W2020236260 @default.
- W4229006237 cites W2059289792 @default.
- W4229006237 cites W2061326496 @default.
- W4229006237 cites W2070177979 @default.
- W4229006237 cites W2075816066 @default.
- W4229006237 cites W2116186936 @default.
- W4229006237 cites W2116376677 @default.
- W4229006237 cites W2116810060 @default.
- W4229006237 cites W2125818823 @default.
- W4229006237 cites W2128646111 @default.
- W4229006237 cites W2128766512 @default.
- W4229006237 cites W2131242848 @default.
- W4229006237 cites W2131401975 @default.
- W4229006237 cites W2158297025 @default.
- W4229006237 cites W2163278718 @default.
- W4229006237 cites W2165558391 @default.
- W4229006237 cites W2188243976 @default.
- W4229006237 cites W2200136802 @default.
- W4229006237 cites W2226146252 @default.
- W4229006237 cites W2272208385 @default.
- W4229006237 cites W2274104936 @default.
- W4229006237 cites W2313068080 @default.
- W4229006237 cites W2395993059 @default.
- W4229006237 cites W2396076356 @default.
- W4229006237 cites W2403903589 @default.
- W4229006237 cites W2610794098 @default.
- W4229006237 cites W2754054868 @default.
- W4229006237 cites W2768119703 @default.
- W4229006237 cites W2790530705 @default.
- W4229006237 cites W2790706219 @default.
- W4229006237 cites W2794293325 @default.
- W4229006237 cites W2799338906 @default.
- W4229006237 cites W2804207405 @default.
- W4229006237 cites W2888543854 @default.
- W4229006237 cites W2913974186 @default.
- W4229006237 cites W2916912835 @default.
- W4229006237 cites W2936329685 @default.
- W4229006237 cites W2956057809 @default.
- W4229006237 cites W2982620423 @default.
- W4229006237 cites W2983929861 @default.
- W4229006237 cites W3004051918 @default.
- W4229006237 cites W3005216696 @default.
- W4229006237 cites W3115840282 @default.
- W4229006237 cites W3132240955 @default.
- W4229006237 cites W3152567463 @default.
- W4229006237 cites W3169262929 @default.
- W4229006237 cites W3188321275 @default.
- W4229006237 cites W3188666769 @default.
- W4229006237 cites W3190053480 @default.
- W4229006237 cites W3190324439 @default.
- W4229006237 cites W4205278313 @default.
- W4229006237 cites W4205447732 @default.
- W4229006237 cites W4226016472 @default.
- W4229006237 cites W4238277289 @default.
- W4229006237 cites W4296024375 @default.
- W4229006237 doi "https://doi.org/10.1136/bmj-2021-069164" @default.
- W4229006237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35508312" @default.
- W4229006237 hasPublicationYear "2022" @default.
- W4229006237 type Work @default.
- W4229006237 citedByCount "10" @default.
- W4229006237 countsByYear W42290062372022 @default.
- W4229006237 countsByYear W42290062372023 @default.
- W4229006237 crossrefType "journal-article" @default.
- W4229006237 hasAuthorship W4229006237A5001379502 @default.
- W4229006237 hasAuthorship W4229006237A5002235223 @default.
- W4229006237 hasAuthorship W4229006237A5010334043 @default.
- W4229006237 hasAuthorship W4229006237A5011877915 @default.
- W4229006237 hasAuthorship W4229006237A5014282030 @default.
- W4229006237 hasAuthorship W4229006237A5026598797 @default.
- W4229006237 hasAuthorship W4229006237A5034810517 @default.